Universal Biosensors, Inc. announced the appointment of a chief executive officer, chairman succession and changes to the board of directors as part of a strategic board renewal process. The company announced the appointment of Rick Legleiter as Chief Executive Officer commencing on 1 October 2017 in Melbourne, Australia. Legleiter replaces Andrew Denver who has been undertaking the role in an interim capacity.

Legleiter was most recently Senior Vice President, Healthcare Account Management. Denver has retired as Chairman of the Board and Executive Director. Denver will be succeeded as Non-Executive Chairman by Craig Coleman.

Coleman was appointed to the Board as a Non-Executive Director in June 2016 and has served as the Chair of the Remuneration & Nomination Committee since that date. Denver will remain with the company in an advisory capacity for a minimum of 12 months. During this period Denver will work with the Board and senior management team to provide a smooth leadership transition, support existing operational initiatives and ensure business and relationship continuity.

Denis Hanley has retired as a Non-Executive Director. Hanley has been a long-standing director of the company since September 2001. Craig Coleman, David Hoey, Judith Smith and Marshall Heinberg will remain as Non-Executive Directors of the company.

The Board has appointed Smith as Chair of the Audit and Compliance Committee.